Search results
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 3 days agoPublic Employees Retirement System of Ohio reduced its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.8% during the 4th quarter, HoldingsChannel reports. The ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoThe company says it will have the results of that study soon. Meanwhile, Pfizer began testing its...
Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC
ETF DAILY NEWS· 5 days agoCresset Asset Management LLC reduced its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent disclosure ...
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 6 days agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Waddell & Associates LLC
ETF DAILY NEWS· 7 days agoWaddell & Associates LLC reduced its position in Pfizer Inc. (NYSE:PFE – Free Report) by 40.0% in the 4th quarter, according to its most recent disclosure with the Securities ...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...